Marc S. Raab, MD, PhD, discusses the different ways that combination therapy that includes teclistamab can benefit patients ...

Value-based oncology care requires balancing rapid innovation with operational sustainability, equitable access, and ...

Radiomics offers improved assessment of spinal cord pathology in MS, surpassing conventional MRI in precision and sensitivity ...

1. Garg S, Donnenfeld E, Sheppard J, Epitropoulos A, Brady TC. Reproxalap improves ocular redness, tear production, and ...

Panelists explain that in the absence of head-to-head trial data, real-world evidence (RWE) becomes crucial in guiding ...

Panelists discuss how real-world outcomes inform patient conversations and support shared decision-making for third-line ...

Mutations in ZRSR2 have been linked with disease progression in patients with JAK2 V617R – driven myeloproliferative ...

Metabolic dysfunction-associated steatotic liver disease (MASLD) is an independent risk factor for major cardiovascular events and for all-cause mortality, according to a new analysis of real-world ...

Neoadjuvant immunochemotherapy shows higher pCR and MPR rates compared to chemotherapy alone in LS-SCLC patients, suggesting enhanced tumor regression before surgery. Propensity score matching ...

Amid rapid advances in oncology, barriers such as treatment costs, health inequities, and clinician burnout remain critical challenges, as highlighted by experts at a regional Institute for ...

CKD and VHD share metabolic, inflammatory, and fibrotic pathways, worsening each other's progression and complicating ...

Amid a government shutdown in nearby Washington, DC, Paul Ryan, former speaker of the House, told attendees at the Academy of ...